The Motley Fool

Key Data Points

Primary metrics and data points about Endocyte, Inc. .
Current Price: $6.13
Prev Close: $6.25
Open: $6.20
Bid: $6.12
Ask: $6.14
Day's Range: $6.02 - $6.25
52wk Range: $5.01 - $9.35
Volume: 393,383
Avg Vol 358,461
Market Cap: $257M
P/E (ttm): 20.83
EPS (ttm): $0.30
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Endocyte, Inc. from Fool.com.

Business Summary

Industry, sector and description for Endocyte, Inc. .

Endocyte Inc is a biopharmaceutical Company developing targeted therapies for the treatment of cancer and inflammatory diseases. It uses its proprietary technology to create novel small molecule drug conjugates or SMDCs and companion imaging diagnose.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

ECYT vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Endocyte, Inc. .
CAPS Rating 3 out of 5
 
103 Outperform
8 Underperform
CAPS All Stars
 
31 Outperform
1 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

P. Ron Ellis, CEO

0% Approve

Based on 0 Ratings

More Details for EndocyteJobs

Powered by

More Details about Endocyte, Inc.

Primary metrics and data points about Endocyte, Inc. .